06Oct 2023
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis

Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis

This retrospective study on 205 idiopathic pulmonary fibrosis (IPF) patients undergoing lung transplantation (LTx) explores the safety of antifibrotic agents (AFAs) pre-LTx. Among 58 patients receiving AFAs, no significant increase in post-operative complications was observed. The AFA group exhibited lower rates of primary graft dysfunction and 90-day mortality, suggesting potential benefits without added risks in the peri-operative period.

  • #pulmonology

Like

Save

Share